CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11502933.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors evaluated whether highly active antiretroviral therapy (HAART) with multiple CSF-penetrating drugs results in greater improvement in HIV-associated psychomotor slowing than HAART with a single CSF-penetrating drug. Both groups had improvement in CD4 count, plasma viral load, as well as two tests of psychomotor speed. Comparing the two groups, there were no differences in the mean change for CD4 count, viral load, or any of the neuropsychological tests. Multiple and single CSF-penetrating HAART may be equivalent for treating HIV-associated psychomotor slowing.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- Cerebrospinal Fluid
- HIV Infections
- Psychomotor Performance